학술논문
Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD‐like receptor family CARD domain‐containing 5.
Document Type
Article
Author
Wada, Asaka; Hirohashi, Yoshihiko; Kutomi, Goro; Murata, Kenji; Iwabuchi, Sadahiro; Mizue, Yuka; Murai, Aiko; Kyuno, Daisuke; Shima, Hiroaki; Minowa, Tomoyuki; Sasaki, Kenta; Kubo, Terufumi; Kanaseki, Takayuki; Tsukahara, Tomohide; Nakatsugawa, Munehide; Hashimoto, Shinichi; Osanai, Makoto; Torigoe, Toshihiko; Takemasa, Ichiro
Source
Cancer Science; Dec2023, Vol. 114 Issue 12, p4511-4520, 10p
Subject
Language
ISSN
13479032
Abstract
Copyright of Cancer Science is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)